Cargando…
Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
BACKGROUND: With ~ 50 million individuals suffering from post-COVID condition (PCC), low health related quality of life (HRQoL) is a vast problem. Common symptoms of PCC, that persists 3 months from the onset of COVID-19 are fatigue, shortness of breath and cognitive dysfunction. No effective treatm...
Autores principales: | Kjellberg, Anders, Hassler, Adrian, Boström, Emil, El Gharbi, Sara, Al-Ezerjawi, Sarah, Kowalski, Jan, Rodriguez-Wallberg, Kenny A., Bruchfeld, Judith, Ståhlberg, Marcus, Nygren-Bonnier, Malin, Runold, Michael, Lindholm, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854077/ https://www.ncbi.nlm.nih.gov/pubmed/36670365 http://dx.doi.org/10.1186/s12879-023-08002-8 |
Ejemplares similares
-
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial
por: Kjellberg, Anders, et al.
Publicado: (2022) -
COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)
por: Kjellberg, Anders, et al.
Publicado: (2023) -
Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience
por: Johansson, Madeleine, et al.
Publicado: (2021) -
Evidence of cytokine activation in patients with post-acute COVID-19 syndrome with- and without postural orthostatic tachycardia syndrome
por: Fredengren, E, et al.
Publicado: (2023) -
Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study
por: Mahdi, Ali, et al.
Publicado: (2023)